Clinical Drug Experience Knowledgebase

Alzheimer Disease (Phase 3)

Arrhythmias, Cardiac (Phase 3)

Attention Deficit Disorder with Hyperactivity (Phase 3)

Birth Weight (Phase 3)

Bone Diseases, Metabolic (Phase 2)

Cachexia (Phase 3)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Celiac Disease (Phase 2)

Chronic Disease (Phase 3)

Cognitive Dysfunction (Phase 1)

Colonic Neoplasms (Phase 2)

Colorectal Neoplasms (Phase 2)

Diabetes, Gestational (Phase 1)

Diabetes Mellitus, Type 2 (Phase 3)

Eclampsia (Phase 1)

Fatty Liver (Phase 3)

Genetic Diseases, Inborn (Phase 2)

Genetic Diseases, X-Linked (Phase 2)

Growth Disorders (Phase 3)

Hypertension, Pregnancy-Induced (Phase 1)

Infant Death (Phase 3)

Insulin Resistance (Phase 3)

Liver Diseases (Phase 3)

Lung Diseases (Phase 3)

Lung Diseases, Obstructive (Phase 3)

Lung Neoplasms (Phase 2)

Malnutrition (Phase 3)

Metabolic Syndrome (Phase 3)

Non-alcoholic Fatty Liver Disease (Phase 3)

Osteoporosis (Phase 2)

Overweight (Phase 3)

Perinatal Death (Phase 3)

Pre-Eclampsia (Phase 1)

Premature Birth (Phase 3)

Pulmonary Disease, Chronic Obstructive (Phase 3)

Rectal Neoplasms (Phase 2)

Retinitis (Phase 2)

Retinitis Pigmentosa (Phase 2)

Wasting Syndrome (Phase 3)